We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Draft FDA Overhaul Bill Broadens Use of Observational Studies, Novel Trial Designs
Draft FDA Overhaul Bill Broadens Use of Observational Studies, Novel Trial Designs
The House Energy and Commerce Committee has released a new draft of its 21st Century Cures Act that would encourage greater use of observational studies, patient registries and real-world therapeutic use to support approvals of new drugs and improve postmarket surveillance.